Cross-sectional study examines mifepristone access at pharmacies after FDA eliminates in-person dispensing requirements, indicating potential improvements in availability.
This cross-sectional study examines access to mifepristone through retail and mail-order pharmacies following the US Food and Drug Administration’s (FDA) removal of its in-person dispensing requirement.
No takes yet. Share an insight, caveat, or question.
Scannell et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: